Report Materials
We conducted this review at the request of 33 Senators.
Medicare Part D payments, excluding dispensing fees, to local, community
pharmacies exceeded the pharmacies' drug acquisition costs by an estimated 18.1
percent when the analysis included rebates that drug wholesalers paid to
pharmacies. Excluding rebates, Part D payments exceeded drug acquisition costs
by an estimated 17.3 percent. The estimated difference between Part D payments
and drug acquisition costs was $9.13 per prescription including rebates and
$8.78 excluding rebates.
The estimated average Medicare Part D dispensing fee paid to local, community
pharmacies was $2.27 per prescription, about $2 less than the average Medicaid
dispensing fee. We recommended that Congress and CMS consider the results of
our review, including the data provided, in any deliberations regarding Medicare
Part D reimbursement. CMS concurred with the recommendation.
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.